icon-folder.gif   Conference Reports for NATAP  
 
  HIVR4P 2024
5th HIV Research for
Prevention Conference
Lima, Peru - Oct 6-10 2024

Back grey_arrow_rt.gif
 
 
 
The role of healthcare-related experiences in willingness and preference for long-acting injectable PrEP (LA-PrEP) among transfeminine persons in the US Transgender Women's Internet Survey and Testing (TWIST) study
 
 
  HIVR4P 2024, the 5th HIV Research for Prevention Conferenc Jennifer L. Glick, PhD, MPH1,2; Danielle F. Nestadt PhD, MPH, MSW2; Travis Sanchez, DVM, MPH3; Iaah Lucas, MPH3; Mariah Valentine-Graves, MPH3; Savannah Winter3; Duygu Islek, MD, PhD3; Sarah M. Murray, PhD 2; Stefan Baral, MD2; Leigh Ragone MS4; Carolyn Brown PhD, MSPH4; Annemiek de Ruiter MD, FRCP4; Vani Vannappagari, PhD, MPH, MBBS4 1 Louisiana State University Health Science Center, School of Public Health; 2 Johns Hopkins Bloomberg School of Public Health; 3 Emory Rollins School of Public Health; 4 ViiV Healthcare

1017241

1017242

1017243

1017244